NCT06255392
- Conditions
- Fludzoparib" and Anti-angiogenic, HRD-Positive/HER2-Negative Advanced Breast Cancer
- Locations
-
- Sun Yat Sen Memorial Hospital，Sun Yat sen University Guangzhou, Guangdong, China
Clinical trial condition
HRD-Positive/HER2-Negative Advanced Breast Cancer
Explore clinical trials studying HRD-Positive/HER2-Negative Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
HRD-Positive/HER2-Negative Advanced Breast Cancer trial results
Active, Not Recruiting
Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer
NCT07371910
- Conditions
- Breast Diseases, Breast Neoplasms, HRD-Positive/HER2-Negative Advanced Breast Cancer, +5 more
- Locations
-
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China